Pricing Log in Create free account

Kyntra Bio Inc (KYNB) vs Pluri Inc. (PLUR)

Kyntra Bio Inc and Pluri Inc. are both Biotechnology companies. Kyntra Bio Inc and Pluri Inc. are of similar size ($15.0M and $14.8M). Pluri Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Pluri Inc. grew revenue faster over the last twelve months: −24.0% against −37.2%. Kyntra Bio Inc has the higher net margin (3,967.8% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 17 metrics below, Kyntra Bio Inc leads on 10 and Pluri Inc. on 7.

Valuation

Metric KYNB PLUR Biotechnology median
P/E 0.08 n/m 10.60
P/S 3.37 11.89 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 15.46 31.96 9.02
Earnings yield 1,179.69% (197.58%) (32.88%)
Free cash flow yield (245.05%) (167.21%) (23.13%)

Profitability

Metric KYNB PLUR Biotechnology median
Gross margin 6.28% 44.59% 68.51%
Operating margin (1,089.78%) (2,454.53%) 0.00%
Net margin 3,967.77% (2,344.59%) 0.00%
Free cash flow margin (824.19%) (1,988.48%) 0.00%
Return on equity (157.83%) 260.35% (51.96%)
Return on assets 131.26% (74.95%) (46.06%)
Return on invested capital 0.00% (526.92%) 0.00%

Growth

Metric KYNB PLUR Biotechnology median
Revenue growth (TTM) (37.15%) (23.95%) 6.76%
EPS growth (last fiscal year) 478.08% 31.46% 29.88%
Revenue growth, 5-year CAGR (48.42%) 113.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYNB PLUR Biotechnology median
Debt to equity 0.00 (1.62) 0.00
Current ratio 2.69 0.27 4.97
Net debt to EBITDA 1.97 (0.83) 1.01

Dividend

Metric KYNB PLUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KYNB PLUR Biotechnology median
Market cap 14.82m 15.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack